TENON MEDICAL INC (TNON)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TNON
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
TNON — private placement
Dated 2026-08-31
Entry into a Material Definitive Agreement. On August 27, 2026, Tenon Medical, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor (the “ Purchaser ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 597,610 shares (the “ Pre-Funded Warrant Shares ”) of the Company’s common stock, par value $0.001 per…
Why it matters: Maintaining compliance is crucial for Tenon's stock to remain listed on Nasdaq.
Watch forTenon maintains a minimum bid price of $1.00 for 30 consecutive days.
Also watch forTenon fails to maintain a minimum bid price of $1.00 for 30 consecutive days.
Why it matters: Staying compliant is key for Tenon to stay on Nasdaq. This affects investor trust.
Worry ifTenon files its Q3 10-Q. This shows it meets Nasdaq's stockholders' equity rule.
Less concerning ifTenon fails to demonstrate compliance in its Q3 10-Q, risking delisting.
Why it matters: Keeping high revenue growth helps the company's plan and market position.
Supportive ifQ3 revenue growth of 100% or more compared to Q3 2025.
Worry ifQ3 revenue growth is under 100%. This shows possible problems in market demand.
Why it matters: Closing this placement will provide funds for growth and debt repayment. It shows investor confidence.
Supportive ifThe company confirms the closing of the $3M private placement by August 31, 2026.
Worry ifThe private placement does not close on time. This shows possible investor worries.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$306 on $10,000 · ±3.1% | How much price usually moves either way. |
| Bad day | $1,165 loss on $10,000 · 11.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,176 loss on $10,000 · 91.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: More surgical cases show that Tenon's products are accepted in the market.
Supportive ifMonthly surgical case volume keeps growing compared to earlier months.
Worry ifMonthly surgical case volume goes down compared to earlier months.
Why it matters: Getting financing is key for Tenon Medical to keep operations and grow. Delays could slow progress.
Supportive ifNew financing agreements have been announced. They total over $5 million.
Worry ifNo new financing agreements announced by the next earnings call.
Why it matters: Maintaining compliance is crucial for Tenon's stock to remain listed on Nasdaq.
Worry ifThe company still meets Nasdaq listing rules after the reverse stock split.
Less concerning ifNot keeping up with Nasdaq rules risks delisting.
Why it matters: More funding can help Tenon grow. This is important for long-term success.
Supportive ifTenon announced a new capital raise. It is over $4 million for expansion.
Worry ifNo new capital raises were announced. This limits growth opportunities.
Why it matters: Controlling costs is key. It helps improve finances and cut losses.
Watch forOperating costs dropped from $4.2 million in Q1 2026.
Also watch forOperating costs rose above $4.2 million in Q2 2026.
Why it matters: News on expansion can show future money-making chances and market plans.
Supportive ifManagement shares updates on new partnerships. They also share training news for surgeons.
Worry ifNo news on expansion plans or delays in projects.
Why it matters: Regaining compliance is important. It helps avoid being removed from Nasdaq. This impacts investor confidence.
Worry ifThe company filed its Q3 2026 10-Q. It shows stockholders' equity over $2.5 million.
Less concerning ifThe Q3 2026 10-Q shows stockholders' equity under $2.5 million. This risks delisting.